| 'Risk of bias' assessment of Jin 2020 | |||
| Domain | Assessed outcomes | Authors' judgement | Support for judgement |
| Representative study group (selection bias) | Not available | High | 6 of 146 COVID‐19 patients in Guizhou Jiangjunshan Hospital who received convalescent plasma therapy included in report |
| Outcome detectors blinded to intervention (detection bias) | Adverse events | High | Not blinded, awareness of intervention can bias assessment of subjective outcomes |
| Complete outcome assessment/follow‐up (attrition bias) | Adverse events | Unclear | Assessed for all participants over study period, observation period unclear |
| Well‐defined study group (reporting bias) | Not available | Unclear | Study population well described, but intervention scarcely described |
| Well‐defined outcome (reporting bias) | Adverse events | High | Reported for all participants, but observation period unclear |
| Well‐defined risk estimates (analyses) | Adverse events | Not applicable | No analyses performed |
| Important prognostic factors or follow‐up taken adequately into account (confounding) | Not available | High | Not adjusted for confounding, results only reported for 6 of 146 participants receiving convalescent plasma |